MOUNTAIN VIEW, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the global leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the American Medical ...
Coverage unlocks reimbursable AI plaque quantification, advancing coronary risk assessment in everyday cardiology ...
Elucid today announced that, effective January 1, 2026, its Plaque-IQ™ coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT®) designation, alongside increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results